Electron Kebebew

Stanford University — United States

Medicine · Health Sciences

114h-index81.1kcitations688works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Thyroid Cancer Diagnosis and Treatment(153), Cancer, Hypoxia, and Metabolism(145), Adrenal and Paraganglionic Tumors(145), Neuroendocrine Tumor Research Advances(100), Hormonal Regulation and Hypertension(70)

Publications606 total

Succinate Dehydrogenase-Deficient Cancer Cells Have Increased Susceptibility to Ym155-Induced DNA Damage
Endocrine Related Cancer·2026
Postnatal development and form-function relationships of the vocal folds in California mice ( <i>Peromyscus californicus</i> )
American Journal of Physiology-Cell Physiology·2026Open Access
Dual targeting of BRAFV600E and ferroptosis results in synergistic anticancer activity via iron overload and enhanced oxidative stress
Journal of Experimental & Clinical Cancer Research·2026· 1 citedOpen Access
Additional file 1 of Dual targeting of BRAFV600E and ferroptosis results in synergistic anticancer activity via iron overload and enhanced oxidative stress
Figshare·2026Open Access
Additional file 1 of Dual targeting of BRAFV600E and ferroptosis results in synergistic anticancer activity via iron overload and enhanced oxidative stress
Figshare·2026Open Access
Corrigendum to “Combination nitazoxanide and auranofin treatment has synergistic anticancer activity in anaplastic thyroid cancer through enhanced activation of oxidative stress that leads to apoptosis” [Cancer Letters 633 (2025) 217990]
Cancer Letters·2025Open Access
Succinate Dehydrogenase-Deficient Cancer Cells Have Increased Susceptibility to Ym155 Induced DNA Damage
2025
Combination nitazoxanide and auranofin treatment has synergistic anticancer activity in anaplastic thyroid cancer through enhanced activation of oxidative stress that leads to apoptosis
Cancer Letters·2025
CRISPR-Based Gene Dependency Screens reveal Mechanism of BRAF Inhibitor Resistance in Anaplastic Thyroid Cancer
2025· 1 citedOpen Access
Dual Targeting of <i> BRAF <sup>V600E</sup> </i> and Ferroptosis Results in Synergistic Anticancer Activity via Iron Overload and Enhanced Oxidative Stress
2025· 1 citedOpen Access
Therapeutic targeting of SDHB-deficient tumors
Endocrine Abstracts·2025
Integrated Single-cell and Plasma Proteomic Modeling to Predict Surgical Site Complications: A Prospective Cohort Study
UNC Libraries·2025· 1 citedOpen Access
Rapidly Growing Thyroid Schwannoma: Diagnostic Challenges and Management Strategies
JCEM Case Reports·2025Open Access
Adrenal surgery
Elsevier eBooks·2025
<i>CDC73</i> c.1155-3A&amp;gt;G is a pathogenic variant that causes aberrant splicing, disrupted parafibromin expression, and hyperparathyroidism-jaw tumor syndrome
JBMR Plus·2024· 1 citedOpen Access
219 (PB207): Dual Targeting of BRAF-V600E and Ferroptosis Results in Synergistic Anticancer Activity via Iron Overload and Enhanced Oxidative Stress
European Journal of Cancer·2024
Parathyroidectomy and the Development of New Depression Among Adults With Primary Hyperparathyroidism
JAMA Surgery·2024· 2 citedOpen Access
Trends in Mortality for Anaplastic Thyroid Cancer: Have We Made Progress?
Journal of Surgical Research·2024· 4 cited
Benefits and Risks Associated With Antibiotic Prophylaxis for Thyroid Operations
Journal of Surgical Research·2024· 1 cited
Beta Probe for Radioguided Surgery in Gastrointestinal Neuroendocrine Tumors: A Move in the Right Direction
Annals of Surgical Oncology·2024Open Access
page 1 of 31Next →

Frequent Co-authors

Orlo H. Clark(14), Quan‐Yang Duh(9), L. Sylvia(7), Giovanni Ciriello(5), Leslie Cope(5), Ludmila Danilova(5), Thomas J. Giordano(5), Katherine A. Hoadley(5), Karel Pacák(5), David L. Steward(5), Julie Weng(5), Corina Millo(5), Ashok R. Shaha(4), Siyuan Zheng(4), Andrew D. Cherniack(4), Ninad Dewal(4), Richard A. Moffitt(4), Bradley A. Murray(4), Antônio Marcondes Lerário(4), Tobias Else(4)